共 138 条
[1]
Louis DN(2016)The 2016 World Health Organization Classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820
[2]
Perry A(2017)Immune microenvironment of gliomas Lab Invest 97 498-518
[3]
Reifenberger G(1996)CTLA-4 ligation blocks CD28-dependent T cell activation J Exp Med 183 2541-2550
[4]
Gieryng A(2004)Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 942-949
[5]
Pszczolkowska D(2009)Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 9 162-174
[6]
Walentynowicz KA(2009)Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer 9 445-452
[7]
Walunas TL(2017)PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome Front Pharmacol 8 561-704
[8]
Bakker CY(2008)PD-1 and its ligands in tolerance and immunity Annu Rev Immunol 26 677-1034
[9]
Bluestone JA(2000)Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation J Exp Med 192 1027-1201
[10]
Curiel TJ(2013)Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells Sci Transl Med 5 200ra116-205